1. Home
  2. List
Reference Patent

Reference - List

  • 7 Hits
  • Search Condition : Filter (MeSH = Erlotinib Hydrochloride / pharmacology)
Species Resource Title
Zebrafish Tg(6xTcf/LefBS-miniP:d2EGFP) Zebrafish drug screening identifies Erlotinib as an inhibitor of Wnt/β-catenin signaling and self-renewal in T-cell acute lymphoblastic leukemia.
Human and Animal Cells Hep G2(RCB1648) Hepatocyte Growth Factor Enhances Antineoplastic Effect of 5-Fluorouracil by Increasing UPP1 Expression in HepG2 Cells.
C.elegans tm2526 , tm2518 Rab8 and Rabin8-Mediated Tumor Formation by Hyperactivated EGFR Signaling via FGFR Signaling.
Human and Animal Cells Ba/F3(RCB0805) , PC-9(RCB4455) TAS6417/CLN-081 Is a Pan-Mutation-Selective EGFR Tyrosine Kinase Inhibitor with a Broad Spectrum of Preclinical Activity against Clinically Relevant EGFR Mutations.
Human and Animal Cells HuH-7 Upregulation of SNX5 predicts poor prognosis and promotes hepatocellular carcinoma progression by modulating the EGFR-ERK1/2 signaling pathway.
Human and Animal Cells Tumor-derived TGF-β and prostaglandin E2 attenuate anti-tumor immune responses in head and neck squamous cell carcinoma treated with EGFR inhibitor.
Human and Animal Cells EBC-1(RCB1965) , Sq-1(RCB1905) , RERF-LC-AI(RCB0444) Anti-HER3 monoclonal antibody patritumab sensitizes refractory non-small cell lung cancer to the epidermal growth factor receptor inhibitor erlotinib.